We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVBN
2851
DELISTED
Evans Bancorp Inc
EVBN
$458K ﹤0.01%
11,412
ADMA icon
2852
ADMA Biologics
ADMA
$2.22B
$456K ﹤0.01%
113,834
BWFG icon
2853
Bankwell Financial Group
BWFG
$537M
$456K ﹤0.01%
15,790
SYRE icon
2854
Spyre Therapeutics
SYRE
$8.88B
$456K ﹤0.01%
2,385
OCUL icon
2855
Ocular Therapeutix
OCUL
$2.06B
$454K ﹤0.01%
114,755
+5,720
+5% +$19.9K
AXTI icon
2856
AXT Inc
AXTI
$4.85B
$453K ﹤0.01%
104,065
SPFI icon
2857
South Plains Financial
SPFI
$840M
$451K ﹤0.01%
+21,596
New +$392K
NESR
2858
National Energy Services Reunited Corp
NESR
$3.6B
$451K ﹤0.01%
49,361
FRBK
2859
DELISTED
Republic First Bancorp Inc
FRBK
$450K ﹤0.01%
107,584
RFL icon
2860
Rafael Holdings
RFL
$106M
$449K ﹤0.01%
25,519
RAPT
2861
DELISTED
RAPT Therapeutics
RAPT
$448K ﹤0.01%
+2,025
New +$373K
REPL icon
2862
Replimune Group
REPL
$1.14B
$448K ﹤0.01%
31,210
+3,548
+13% +$51.1K
MSON
2863
DELISTED
Misonix Inc
MSON
$448K ﹤0.01%
24,066
+6,567
+38% +$120K
WLFC icon
2864
Willis Lease Finance
WLFC
$1.19B
$444K ﹤0.01%
22,599
+1,083
+5% +$21.1K
KVHI icon
2865
KVH Industries
KVHI
$143M
$442K ﹤0.01%
39,626
NAGE
2866
Niagen Bioscience
NAGE
$237M
$442K ﹤0.01%
102,441
+5,177
+5% +$18.4K
CDZI icon
2867
Cadiz
CDZI
$289M
$441K ﹤0.01%
39,978
+6,495
+19% +$74.9K
SNDX icon
2868
Syndax Pharmaceuticals
SNDX
$1.8B
$441K ﹤0.01%
50,164
ALRS icon
2869
Alerus Financial
ALRS
$831M
$438K ﹤0.01%
+19,143
New +$420K
AMRS
2870
DELISTED
Amyris Inc.
AMRS
$438K ﹤0.01%
141,542
+48,993
+53% +$182K
CRMD icon
2871
CorMedix
CRMD
$578M
$437K ﹤0.01%
59,892
+4,911
+9% +$30K
PKD
2872
DELISTED
Parker Drilling Company
PKD
$437K ﹤0.01%
19,411
UNTY icon
2873
Unity Bancorp
UNTY
$600M
$436K ﹤0.01%
19,284
BFIN
2874
DELISTED
BankFinancial
BFIN
$435K ﹤0.01%
33,244
PBFS icon
2875
Pioneer Bancorp
PBFS
$437M
$435K ﹤0.01%
28,389
+5,272
+23% +$71.3K

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.